Clinical Trials in Chattanooga, United States
Locations / Chattanooga, United States
Delta Trials records 1,977 clinical trials conducted in Chattanooga, United States, making it a notable site of clinical research activity. These trials across 2,439 distinct therapeutic areas, reflecting the scope and diversity of clinical research in this location. Since 2020, 260 trials in this location were terminated, reflecting shifts in research priorities or feasibility. Delta Trials updates this record as new data becomes available from ClinicalTrials.gov, providing a versioned view of how research activity in Chattanooga has changed over time.
1977
Total Trials
2439
Conditions
260
Terminated since 2020
Browse by condition (2439 total)
- Diabetes mellitus, type 2 87 trialsAll Diabetes mellitus, type 2 trials
- Breast cancer 58 trialsAll Breast cancer trials
- Diabetes 54 trialsAll Diabetes trials
- Non-small cell lung cancer 51 trialsAll Non-small cell lung cancer trials
- Obesity 24 trialsAll Obesity trials
- Colorectal cancer 23 trialsAll Colorectal cancer trials
- Lung cancer 22 trialsAll Lung cancer trials
- Prostate cancer 22 trialsAll Prostate cancer trials
- Atrial fibrillation 21 trialsAll Atrial fibrillation trials
- Diabetes mellitus, type 1 20 trialsAll Diabetes mellitus, type 1 trials
- Stroke 20 trialsAll Stroke trials
- Type 2 diabetes mellitus 20 trialsAll Type 2 diabetes mellitus trials
- Heart failure 19 trialsAll Heart failure trials
- Chronic lymphocytic leukemia 18 trialsAll Chronic lymphocytic leukemia trials
- Ovarian cancer 18 trialsAll Ovarian cancer trials
- Metastatic breast cancer 16 trialsAll Metastatic breast cancer trials
- Endometriosis 16 trialsAll Endometriosis trials
- Irritable bowel syndrome 16 trialsAll Irritable bowel syndrome trials
- Ischemic stroke 16 trialsAll Ischemic stroke trials
- Constipation 16 trialsAll Constipation trials